Driving reinvestment in R&D for antibiotics and advocating their responsible use


DRIVE-AB contributes to Uppsala Health Summit, ‘A World Without Antibiotics’ 2-3 June, 2015

On 2-3 June 2015, members of DRIVE-AB helped to deliver an International Health Summit titled 'A World Without Antibiotics' which was held in Uppsala, Sweden, to bring together experts, delegates of civil society, and industry from around the world to discuss possible solutions to the global threat of antibiotic resistance. At the Uppsala Health Summit 2015, the focus of the dialogue was on how our current state of knowledge and research and development capacity can be used and built upon to take steps on global, national and local levels to reduce the threat from antibiotic resistance. Issues discussed in workshops and in the plenary included:
  • -...
Read more

Uppsala University to invest in Antibiotics Centre

Deputy Vice-Chancellor Anders Malmberg announced today at the opening of the Uppsala Health Summit conference that Uppsala University is creating an Antibiotics Centre. The goal is for this interdisciplinary centre to be a regional, national and international knowledge resource and forum in the area of antibiotic resistance.
‘We want to assume responsibility and take up the urgent challenge in this matter, which is so pressing for humankind. Here, we have a unique capacity to do it with the interdisciplinary approach that’s required,’ says Anders Malmberg, Deputy Vice-Chancellor.
Click here to read the Press Release.  ...
Read more

World Health Assembly formally agrees on Global Action Plan to tackle antimicrobial resistance

On 25 May, 2015, the 68th World Health Assembly formally endorsed a Global Action Plan to tackle antimicrobial resistance. The plan outlines ways to ensure, for as long as possible, the continuity of successful treatment and prevention of infectious diseases with effective and safe medicines that are quality-assured, used in a responsible way, and accessible to all who need them. All Member States have committed to have their own national action plans, aligned with the global action plan, in place by May 2017. The plans must cover the use of antimicrobials in human health, animal health, and agriculture. Read the World Health Organization Read more

DRIVE-AB Participants Comment on UK Review on AMR Report

In response to the Review on Antimicrobial Resistance report that was released today, "Securing new drugs for future generations: The pipeline of antibiotics", three  DRIVE-AB members, one external Work Package 2 partner and two participants of the Work Package 3B Stakeholder Platform and External Communication group, have released commentaries on the recommendations put forth by the Review. The Review on Antimicrobial Resistance makes bold recommendations to address the issue of incentivising research and development of new antibiotics on a global scale. Prof Kevin Outterson, Dr Charles Clift, and Prof Laura Piddock provide comments on these recommendations: Read more

Review on Antimicrobial Resistance proposes ways to drive development of new drugs

The Review on Antimicrobial Resistance, often referred to as the O'Neill Review, was commissioned by the UK Prime Minister David Cameron and is chaired by esteemed economic Jim O'Neill. On May 14, 2015, the Review published their third report, titled, "Securing new drugs for future generations: The pipeline of antibiotics". This report examines the need to boost the development of new antibiotic drugs, and proposes national and international strategies that will meet those needs, including reforms to the current economic models surrounding antibiotic development and sales. View the report: Securing new drugs for future generations: The pipeline...
Read more